The article focuses on the treatment of prostate cancer. It explains the use of antineoplastic agents including luteinising hormone-releasing hormone (LHRH) agonists or gonadorelin analogues, as well as notes other approaches which include active monitoring or surveillance, surgery and radiotherapy. ...
Indeed, with the growing use of other systemic treatments in the metastatic hormone-sensitive prostate cancer space, there could be a role for radium-223 at the time of development of castration resistance in patients whose disease is already resistant to novel hormonal agents and/or docetaxel ...
The goal of prostate cancer treatment isn't just to remove the cancer but to preserve the patient's quality of life. Specialized centers like the 'Changzheng Urology Pelvic Center' in Shanghai are dedicated to comprehensive post-operative care, focusing on urinary control and sexual function. Thi...
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.
Black patients with prostate cancer have historically been underrepresented in clinical trials, leading to insufficient data on the effectiveness and safety of new treatments for this group.1 In a phase II trial involving 100 patients with metastatic castration-resistant prostate cancer (mCRPC), 50 ...
PARP (poly ADP-ribose polymerase) inhibitors have recently emerged as a new treatment option for metastatic castration-resistant prostate cancer (mCRPC) with a poor prognosis and are expected to contribute significantly to improving survival rates.Howeve
Autophagy is a survival mechanism that cancer cells use to deal with metabolic stress caused by various treatments, such as castration therapy. Additionally, autophagy has been shown to promote castration resistance. Evidence suggests that the expression of CAMKK2, AMPK, and ULK1 in males with PCa...
Other prostate cancer symptoms can include: Loss of libido (sex drive).Side effects of drug treatments for prostate cancer can cause a loss of interest in sex and erection problems. A common treatment for prostate cancer is hormone therapy, which is used to slow your body down from making te...
MYC drives the tumorigenesis of human cancers, including prostate cancer (PrCa), thus deubiquitinase (DUB) that maintains high level of c-Myc oncoprotein is a rational therapeutic target. Several ubiquitin-specific protease (USP) family members of DUB ha
Depending on the man's age and the amount of surgery needed to remove all the cancer, nerve-sparing operations allow many men who were able to get erections before surgery to be able to do so after surgery without the need for erectile dysfunction treatments. Laparoscopic robotic prostatectomy...